Evidence map›Paper›PMID 27429556›Full record

ArticleHealth services insights2016

Cost-effectiveness of SHINE: A Telephone Translation of the Diabetes Prevention Program.

Christopher S Hollenbeak, Ruth S Weinstock, Donald Cibula, Linda M Delahanty, Paula M Trief

Open access · goldAbstract read
In one paragraph

Article in Health services insights, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Christopher S HollenbeakDepartments of Surgery and Public Health Sciences, The Pennsylvania State University, College of Medicine, Hershey, PA, USA.
Ruth S WeinstockDepartments of Medicine, and Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA.
Donald CibulaDepartment of Public Health and Preventive Medicine, SUNY Upstate Medical University, Syracuse, NY, USA.
Linda M DelahantyDepartment of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Paula M TriefDepartments of Medicine, Psychiatry and Behavioral Sciences, and Orthopedic Surgery, SUNY Upstate Medical University, Syracuse, NY, USA.
Massachusetts General Hospital · USSUNY Upstate Medical University · US

Funding

Weight Loss in Primary Care: A Translation of the Diabetes Prevention ProgramR18DK078553 · NIDDK · UPSTATE MEDICAL UNIVERSITY · PI TRIEF, PAULA MARY, WEINSTOCK, RUTH S · 2008 to 2012
$3.2M
NIDDK NIH HHS R18 DK078553
6 · The paper itself

Abstract

backgroundThe Support, Health Information, Nutrition, and Exercise (SHINE) trial recently showed that a telephone adaptation of the Diabetes Prevention Program (DPP) lifestyle intervention was effective in reducing weight among patients with metabolic syndrome. The aim of this study is to determine whether a conference call (CC) adaptation was cost effective relative to an individual call (IC) adaptation of the DPP lifestyle intervention in the primary care setting.

methodsWe performed a stochastic cost-effectiveness analysis alongside a clinical trial comparing two telephone adaptations of the DPP lifestyle intervention. The primary outcomes were incremental cost-effectiveness ratios estimated for weight loss, body mass index (BMI), waist circumference, and quality-adjusted life years (QALYs). Costs were estimated from the perspective of society and included direct medical costs, indirect costs, and intervention costs.

resultsAfter one year, participants receiving the CC intervention accumulated fewer costs ($2,831 vs. $2,933) than the IC group, lost more weight (6.2 kg vs. 5.1 kg), had greater reduction in BMI (2.1 vs. 1.9), and had greater reduction in waist circumference (6.5 cm vs. 5.9 cm). However, participants in the CC group had fewer QALYs than those in the IC group (0.635 vs. 0.646). The incremental cost-effectiveness ratio for CC vs. IC was $9,250/QALY, with a 48% probability of being cost-effective at a willingness-to-pay of $100,000/QALY.

conclusionsCC delivery of the DPP was cost effective relative to IC delivery in the first year in terms of cost per clinical measure (weight lost, BMI, and waist circumference) but not in terms of cost per QALY, most likely because of the short time horizon.

Indexed as

cost-effectiveness anlaysisdiabetesdiabetes prevention program

Identifiers

PMID27429556
PMCPMC4936790
OpenAlexW2469743899

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.